Position in MRK
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,590,945
+$325,163 QoQ
Shares Held
20,163
+7.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#1,430
of 3,769 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mayflower Financial Advisors, LLC holds $56,704,468 across 12 Drug Manufacturers - General names. MRK ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
101,672 | $25,584,742 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
208,112 | $11,991,413 | |
| 3 | JNJ |
Johnson & Johnson
|
24,544 | $6,233,439 | |
| 4 | LLY |
ELI LILLY & Co
|
3,906 | $4,684,973 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
20,163 | $2,590,945 | |
| 6 | PFE |
Pfizer Inc
|
58,088 | $1,398,759 | |
| 7 | NVS |
Novartis AG
|
8,591 | $1,346,381 | |
| 8 | AMGN |
Amgen Inc
|
3,665 | $1,327,169 |
All Filings in MRK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,590,945 | 20,163 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $2,265,782 | 18,836 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $2,003,203 | 19,031 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $1,618,086 | 19,279 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,588,424 | 20,066 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,884,960 | 21,000 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,543,902 | 25,572 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $2,852,854 | 25,122 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $3,266,463 | 26,385 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $3,579,143 | 27,125 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $2,958,693 | 27,139 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $2,852,126 | 27,704 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $3,276,729 | 28,397 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $3,071,585 | 28,871 | Shares | Sole | 2023-04-12 | |
| 2022-06-30 | $2,607,826 | 28,604 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $2,161,771 | 26,347 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $1,942,517 | 25,346 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,945,799 | 25,906 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $2,581,186 | 33,190 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $2,174,170 | 28,203 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,384,550 | 29,151 | Shares | Sole | 2021-04-12 | |
| No filing history on record for this holder in this stock. | ||||||